2025-04-012026-03-312026-03-31false14752534REALIGN HEALTH LTD2026-07-14falseiso4217:GBPxbrli:pure147525342025-03-31147525342026-03-31147525342025-04-012026-03-31147525342024-03-31147525342025-03-31147525342024-04-012025-03-3114752534bus:SmallEntities2025-04-012026-03-3114752534bus:AuditExempt-NoAccountantsReport2025-04-012026-03-3114752534bus:FullAccounts2025-04-012026-03-3114752534bus:PrivateLimitedCompanyLtd2025-04-012026-03-3114752534core:WithinOneYear2026-03-3114752534core:AfterOneYear2026-03-3114752534core:WithinOneYear2025-03-3114752534core:AfterOneYear2025-03-3114752534core:ShareCapital2026-03-3114752534core:SharePremium2026-03-3114752534core:RevaluationReserve2026-03-3114752534core:OtherReservesSubtotal2026-03-3114752534core:RetainedEarningsAccumulatedLosses2026-03-3114752534core:ShareCapital2025-03-3114752534core:SharePremium2025-03-3114752534core:RevaluationReserve2025-03-3114752534core:OtherReservesSubtotal2025-03-3114752534core:RetainedEarningsAccumulatedLosses2025-03-3114752534core:LandBuildings2026-03-3114752534core:PlantMachinery2026-03-3114752534core:Vehicles2026-03-3114752534core:FurnitureFittings2026-03-3114752534core:OfficeEquipment2026-03-3114752534core:NetGoodwill2026-03-3114752534core:IntangibleAssetsOtherThanGoodwill2026-03-3114752534core:ListedExchangeTraded2026-03-3114752534core:UnlistedNon-exchangeTraded2026-03-3114752534core:LandBuildings2025-03-3114752534core:PlantMachinery2025-03-3114752534core:Vehicles2025-03-3114752534core:FurnitureFittings2025-03-3114752534core:OfficeEquipment2025-03-3114752534core:NetGoodwill2025-03-3114752534core:IntangibleAssetsOtherThanGoodwill2025-03-3114752534core:ListedExchangeTraded2025-03-3114752534core:UnlistedNon-exchangeTraded2025-03-3114752534core:LandBuildings2025-04-012026-03-3114752534core:PlantMachinery2025-04-012026-03-3114752534core:Vehicles2025-04-012026-03-3114752534core:FurnitureFittings2025-04-012026-03-3114752534core:OfficeEquipment2025-04-012026-03-3114752534core:NetGoodwill2025-04-012026-03-3114752534core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3114752534core:ListedExchangeTraded2025-04-012026-03-3114752534core:UnlistedNon-exchangeTraded2025-04-012026-03-3114752534core:MoreThanFiveYears2025-04-012026-03-3114752534core:Non-currentFinancialInstruments2026-03-3114752534core:Non-currentFinancialInstruments2025-03-3114752534dpl:CostSales2025-04-012026-03-3114752534dpl:DistributionCosts2025-04-012026-03-3114752534core:LandBuildings2025-04-012026-03-3114752534core:PlantMachinery2025-04-012026-03-3114752534core:Vehicles2025-04-012026-03-3114752534core:FurnitureFittings2025-04-012026-03-3114752534core:OfficeEquipment2025-04-012026-03-3114752534dpl:AdministrativeExpenses2025-04-012026-03-3114752534core:NetGoodwill2025-04-012026-03-3114752534core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3114752534dpl:GroupUndertakings2025-04-012026-03-3114752534dpl:ParticipatingInterests2025-04-012026-03-3114752534dpl:GroupUndertakingscore:ListedExchangeTraded2025-04-012026-03-3114752534core:ListedExchangeTraded2025-04-012026-03-3114752534dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-04-012026-03-3114752534core:UnlistedNon-exchangeTraded2025-04-012026-03-3114752534dpl:CostSales2024-04-012025-03-3114752534dpl:DistributionCosts2024-04-012025-03-3114752534core:LandBuildings2024-04-012025-03-3114752534core:PlantMachinery2024-04-012025-03-3114752534core:Vehicles2024-04-012025-03-3114752534core:FurnitureFittings2024-04-012025-03-3114752534core:OfficeEquipment2024-04-012025-03-3114752534dpl:AdministrativeExpenses2024-04-012025-03-3114752534core:NetGoodwill2024-04-012025-03-3114752534core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3114752534dpl:GroupUndertakings2024-04-012025-03-3114752534dpl:ParticipatingInterests2024-04-012025-03-3114752534dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3114752534core:ListedExchangeTraded2024-04-012025-03-3114752534dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3114752534core:UnlistedNon-exchangeTraded2024-04-012025-03-3114752534core:NetGoodwill2026-03-3114752534core:IntangibleAssetsOtherThanGoodwill2026-03-3114752534core:LandBuildings2026-03-3114752534core:PlantMachinery2026-03-3114752534core:Vehicles2026-03-3114752534core:FurnitureFittings2026-03-3114752534core:OfficeEquipment2026-03-3114752534core:AfterOneYear2026-03-3114752534core:WithinOneYear2026-03-3114752534core:ListedExchangeTraded2026-03-3114752534core:UnlistedNon-exchangeTraded2026-03-3114752534core:ShareCapital2026-03-3114752534core:SharePremium2026-03-3114752534core:RevaluationReserve2026-03-3114752534core:OtherReservesSubtotal2026-03-3114752534core:RetainedEarningsAccumulatedLosses2026-03-3114752534core:NetGoodwill2025-03-3114752534core:IntangibleAssetsOtherThanGoodwill2025-03-3114752534core:LandBuildings2025-03-3114752534core:PlantMachinery2025-03-3114752534core:Vehicles2025-03-3114752534core:FurnitureFittings2025-03-3114752534core:OfficeEquipment2025-03-3114752534core:AfterOneYear2025-03-3114752534core:WithinOneYear2025-03-3114752534core:ListedExchangeTraded2025-03-3114752534core:UnlistedNon-exchangeTraded2025-03-3114752534core:ShareCapital2025-03-3114752534core:SharePremium2025-03-3114752534core:RevaluationReserve2025-03-3114752534core:OtherReservesSubtotal2025-03-3114752534core:RetainedEarningsAccumulatedLosses2025-03-3114752534core:NetGoodwill2024-03-3114752534core:IntangibleAssetsOtherThanGoodwill2024-03-3114752534core:LandBuildings2024-03-3114752534core:PlantMachinery2024-03-3114752534core:Vehicles2024-03-3114752534core:FurnitureFittings2024-03-3114752534core:OfficeEquipment2024-03-3114752534core:AfterOneYear2024-03-3114752534core:WithinOneYear2024-03-3114752534core:ListedExchangeTraded2024-03-3114752534core:UnlistedNon-exchangeTraded2024-03-3114752534core:ShareCapital2024-03-3114752534core:SharePremium2024-03-3114752534core:RevaluationReserve2024-03-3114752534core:OtherReservesSubtotal2024-03-3114752534core:RetainedEarningsAccumulatedLosses2024-03-3114752534core:AfterOneYear2025-04-012026-03-3114752534core:WithinOneYear2025-04-012026-03-3114752534core:Non-currentFinancialInstrumentscore:CostValuation2025-04-012026-03-3114752534core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-04-012026-03-3114752534core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-04-012026-03-3114752534core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-04-012026-03-3114752534core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-04-012026-03-3114752534core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-04-012026-03-3114752534core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3114752534core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3114752534core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3114752534core:Non-currentFinancialInstrumentscore:CostValuation2026-03-3114752534core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-03-3114752534core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-03-3114752534core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-03-3114752534core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-03-3114752534core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-03-3114752534core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-03-3114752534core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-03-3114752534core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-03-3114752534core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3114752534core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3114752534core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3114752534core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3114752534core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3114752534core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3114752534core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3114752534core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3114752534core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3114752534bus:Director12025-04-012026-03-31

REALIGN HEALTH LTD

Registered Number
14752534
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2026

REALIGN HEALTH LTD
Company Information
for the year from 1 April 2025 to 31 March 2026

Director

BINDER, Benjamin Leslie

Registered Address

C/O Census Accountancy
13 West Street
Dunstable
LU6 1SX

Registered Number

14752534 (England and Wales)
REALIGN HEALTH LTD
Balance Sheet as at
31 March 2026

Notes

2026

2025

£

£

£

£

Current assets
Cash at bank and on hand8,68213,603
8,68213,603
Creditors amounts falling due within one year3(8,632)(13,531)
Net current assets (liabilities)5072
Total assets less current liabilities5072
Net assets5072
Capital and reserves
Profit and loss account5072
Shareholders' funds5072
The financial statements were approved and authorised for issue by the Director on 14 July 2026, and are signed on its behalf by:
BINDER, Benjamin Leslie
Director
Registered Company No. 14752534
REALIGN HEALTH LTD
Notes to the Financial Statements
for the year ended 31 March 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
2.Average number of employees

20262025
Average number of employees during the year00
3.Creditors: amounts due within one year

2026

2025

££
Taxation and social security3,5668,531
Other creditors5,0665,000
Total8,63213,531